ETHAMBUTOL HYDROCHLORIDE
ETHAMBUTOL HYDROCHLORIDE is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: ETHAMBUTOL HYDROCHLORIDE; Generic name: ETHAMBUTOL HYDROCHLORIDE; Manufacturer: Epic Pharma, LLC.
| Brand name | ETHAMBUTOL HYDROCHLORIDE |
|---|---|
| Generic name | ETHAMBUTOL HYDROCHLORIDE |
| Manufacturer | Epic Pharma, LLC |
| Used for | INDICATIONS AND USAGE Ethambutol Hydrochloride Tablets, USP are indicated for the treatment of pulmonary tuberculosis. It should not be used as the sole antituberculous drug, but should be used in conjunction with at least one other antituberculous drug. Selection of the companion drug should be based on clinical experience, considerations of comparative safety, and appropriate in vitro susceptibility studies. In patients who have not received previous antituberculous therapy, i.e., initial treatment, the most frequently used regimens have been the following: Ethambutol hydrochloride, USP plus isoniazid Ethambutol hydrochloride, USP plus isoniazid plus streptomycin In patients who have recei |
| Dosage | DOSAGE AND ADMINISTRATION Ethambutol hydrochloride should not be used alone, in initial treatment or in retreatment. Ethambutol hydrochloride should be administered on a once every 24-hour basis only. Absorption is not significantly altered by administration with food. Therapy, in general, should be continued until bacteriological conversion has become permanent and maximal clinical improvement has occurred. Ethambutol hydrochloride is not recommended for use in pediatric patients under 13 years |
| Warnings | WARNINGS Ethambutol hydrochloride may produce decreases in visual acuity which appear to be due to optic neuritis. This effect may be related to dose and duration of treatment. This effect is generally reversible when administration of the drug is discontinued promptly. However, irreversible blindness has been reported. (See PRECAUTIONS and ADVERSE REACTIONS ). Liver toxicities including fatalities have been reported (See ADVERSE REACTIONS ). Baseline and periodic assessment of hepatic function |
| Active ingredient(s) | ETHAMBUTOL HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=08decdf3-a397-42e7-8ac3-e489c0cc7085 |